Condition: Oral Squamous Cell Carcinoma · Oral Cancer · Head and Neck Cancer · Sponsor: Case Comprehensive Cancer Center
The goal of this phase II single arm clinical study is to evaluate the effect of antibiotics (metronidazole) and oral chlorhexidine (CHX) in reducing the bacteria load within tumors of patients undergoing surgery for oral cancer.
This description comes directly from the study's public registry record.
Natalie Silver, MD · 216-219-3267 · silvern@ccf.org
Always discuss trial participation with your own doctor first.
| Case Comprehensive Cancer Center, Cleveland Clinic Foundation | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06627270